author-photo

Ellen Townley

11

Papers

159

Citations

Citation Trend

Filter By

Papers (8) Sort By

Journal Conference Others

Pharmacokinetics, Safety, Tolerability and Antiviral Activity of Dolutegravir Dispersible Tablets in Infants and Children with HIV-1: Results of the IMPAACT P1093 Study, a Phase I/II Open-Label Trial

2021
Show All
- Source
- Cite
- Save
Citations (0)
Etravirine in treatment-experienced HIV-1 infected children 1-<6 years of age.

2021 AIDS
Show All
- Source
- Cite
- Save
Citations (1)
Pharmacokinetics and Safety of Three Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women.

2021 Clinical Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Pharmacokinetics and Safety of a Raltegravir-Containing Regimen in Children Aged 4 Weeks to 2 Years Living With Human Immunodeficiency Virus and Receiving Rifampin for Tuberculosis.

2020 Journal of the Pediatric Infectious Diseases Society
Show All
- Source
- Cite
- Save
Citations (1)
Pharmacokinetics and safety of a raltegravir containing regimen in HIV-infected children aged 2 to 12 years on rifampicin for tuberculosis

2019 AIDS
Show All
- Source
- Cite
- Save
Citations (2)
Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents: Forty-eight-week Results from IMPAACT P1093.

2015 Pediatric Infectious Disease Journal
Show All
- Source
- Cite
- Save
Citations (35)
Long-Term Safety and Efficacy of Dolutegravir in HIV Treatment-Experienced Adolescents

2015 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Safety, Pharmacokinetics, and Pharmacodynamics of Cyclodextrin Itraconazole in Pediatric Patients with Oropharyngeal Candidiasis

2002 Antimicrobial Agents and Chemotherapy
Show All
- Source
- Cite
- Save
Citations (99)